PROTHENA CORPORATION PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.1 USD | -6.90% |
|
-10.23% | -44.69% |
| May. 09 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
| May. 08 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 631.6 | 479.5 | 2,302 | 3,111 | 1,950 | 1,161 | - | - |
| Enterprise Value (EV) 1 | 631.6 | 479.5 | 2,302 | 3,111 | 1,331 | 1,161 | 1,161 | 1,161 |
| P/E ratio | -8.12 x | -4.32 x | 35.8 x | -24.4 x | -13.2 x | -4.59 x | -5.09 x | -7.95 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 776 x | 562 x | 11.5 x | 57.7 x | 21.3 x | 76.9 x | 13.2 x | 5.5 x |
| EV / Revenue | 776 x | 562 x | 11.5 x | 57.7 x | 21.3 x | 76.9 x | 13.2 x | 5.5 x |
| EV / EBITDA | - | -4,310,881 x | 31,491,761 x | - | -10,258,370 x | - | - | - |
| EV / FCF | -11.7 x | -5.95 x | 25 x | - | -14.3 x | -4.8 x | -11.4 x | -9.83 x |
| FCF Yield | -8.56% | -16.8% | 4% | - | -7.01% | -20.8% | -8.77% | -10.2% |
| Price to Book | - | - | - | - | 3.44 x | - | - | - |
| Nbr of stocks (in thousands) | 39,897 | 39,921 | 46,594 | 51,627 | 53,665 | 53,772 | - | - |
| Reference price 2 | 15.83 | 12.01 | 49.40 | 60.25 | 36.34 | 21.59 | 21.59 | 21.59 |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.814 | 0.853 | 200.6 | 53.9 | 91.37 | 15.09 | 88.26 | 211.1 |
| EBITDA | - | -111.2 | 73.09 | - | -190.1 | - | - | - |
| EBIT 1 | -85.7 | -112.7 | 71.98 | -131.6 | -191 | -289.5 | -250 | -160 |
| Operating Margin | -10,527.89% | -13,216.18% | 35.88% | -244.05% | -209.08% | -1,917.94% | -283.24% | -75.77% |
| Earnings before Tax (EBT) 1 | -77.3 | -111.4 | 71.92 | -125.6 | -160.5 | -262.3 | -263.5 | -146.7 |
| Net income 1 | -77.68 | -111.1 | 66.98 | -116.9 | -147 | -250.5 | -217.7 | -164.6 |
| Net margin | -9,542.63% | -13,029.78% | 33.39% | -216.95% | -160.91% | -1,659.6% | -246.63% | -77.96% |
| EPS 2 | -1.950 | -2.780 | 1.380 | -2.470 | -2.760 | -4.701 | -4.242 | -2.717 |
| Free Cash Flow 1 | -54.06 | -80.56 | 92.03 | - | -136.7 | -242 | -101.8 | -118.1 |
| FCF margin | -6,641.65% | -9,444.08% | 45.88% | - | -149.63% | -1,603.62% | -115.29% | -55.93% |
| FCF Conversion (EBITDA) | - | - | 125.91% | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | 137.41% | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1.172 | 1.153 | 1.312 | 1.517 | 49.92 | 2.169 | 4.019 | 84.87 | 0.316 | 0.05 | 1.839 | 1.839 | 11.36 | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -33.09 | -37.94 | -43.21 | -50.33 | -0.072 | -56.32 | -66.5 | 10.31 | -78.52 | -81.53 | -74.08 | -73.69 | -60.2 | -80.73 | -82.78 |
| Operating Margin | -2,823.55% | -3,290.89% | -3,293.37% | -3,317.86% | -0.14% | -2,596.82% | -1,654.74% | 12.15% | -24,846.52% | -163,056% | -4,028.63% | -4,007.7% | -529.88% | - | - |
| Earnings before Tax (EBT) 1 | -33.1 | -37.96 | -42.57 | -48.42 | 3.345 | -49.78 | -58.9 | 18.82 | -70.62 | -74.44 | -68.65 | -68.81 | -51.58 | -70.15 | -72.18 |
| Net income 1 | -33.18 | -36.29 | -41.24 | -45.76 | 6.349 | -46.86 | -54.6 | 21.91 | -67.48 | -72.24 | -65.69 | -65.94 | -51.73 | -75.58 | -77.59 |
| Net margin | -2,830.97% | -3,147.44% | -3,143.6% | -3,016.74% | 12.72% | -2,160.63% | -1,358.42% | 25.81% | -21,353.16% | -144,478% | -3,572.34% | -3,586.26% | -455.31% | - | - |
| EPS 2 | -0.7100 | -0.7800 | -0.8800 | -0.9700 | 0.1200 | -0.8900 | -1.030 | 0.3800 | -1.260 | -1.340 | -1.222 | -1.211 | -1.013 | -1.470 | -1.515 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/17/22 | 5/5/22 | 8/8/22 | 11/3/22 | 2/23/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/15/24 | 5/8/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | 619 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -54.1 | -80.6 | 92 | - | -137 | -242 | -102 | -118 |
| ROE (net income / shareholders' equity) | -26.1% | -48.6% | 20.6% | -21.5% | -24.8% | -56.6% | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | -20.2% | - | - | - |
| Assets 1 | - | - | - | - | 727.2 | - | - | - |
| Book Value Per Share | - | - | - | - | 10.50 | - | - | - |
| Cash Flow per Share 2 | -1.330 | -2.010 | 1.910 | - | -2.520 | -3.610 | -5.130 | - |
| Capex 1 | 0.56 | 0.2 | 0.58 | - | 2.81 | 0.28 | 0.53 | 0.59 |
| Capex / Sales | 68.18% | 22.98% | 0.29% | - | 3.08% | 1.82% | 0.61% | 0.28% |
| Announcement Date | 2/12/20 | 2/11/21 | 2/17/22 | 2/23/23 | 2/15/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
21.59
USD
Average target price
64.75
USD
Spread / Average Target
+199.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -44.69% | 1.16B | |
| +10.79% | 115B | |
| +11.65% | 106B | |
| -6.20% | 24.69B | |
| -2.33% | 21.97B | |
| -6.03% | 19.27B | |
| -13.41% | 17.56B | |
| -40.50% | 17.32B | |
| +6.64% | 14.03B | |
| +31.84% | 12.13B |
- Stock Market
- Equities
- PRTA Stock
- Financials Prothena Corporation plc
